Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study
Author:
Funder
Daewoong Pharmaceutical Company
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference48 articles.
1. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial;Miller;Journal of the American College of Cardiology,2008
2. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial;Keech;Lancet,2005
3. Effects of combination lipid therapy in type 2 diabetes mellitus;Ginsberg;The New England Journal of Medicine,2010
4. Predicting the effect of fenofibrate on cardiovascular risk for individual patients with type 2 diabetes;Koopal;Diabetes Care,2018
5. Efficacy and safety of pemafibrate versus fenofibrate in patients with high triglyceride and low HDL cholesterol levels: a multicenter, placebo-controlled, double-blind, randomized trial;Arai;Journal of atherosclerosis and thrombosis,2018
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review;Diabetes & Metabolism Journal;2024-03-31
2. Lipid-lowering therapy for hypertriglyceridemia-induced acute pancreatitis: Recent advances;World Chinese Journal of Digestology;2023-11-08
3. Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome;Diseases;2023-10-13
4. Metabolomics and Lipidomics Study Unveils the Impact of Tauroursodeoxycholic Acid on Hyperlipidemic Mice;Molecules;2023-08-30
5. Therapeutic roles of PPARα activation in ocular ischemic diseases;HISTOL HISTOPATHOL;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3